期刊文献+

结缔组织病相关肺动脉高压抗内皮细胞抗体检测及其靶抗原研究 被引量:5

Specific anti-moesin antibodies could be detected in patients with pulmonary arterial hypertension associated with connective tissue diseases
原文传递
导出
摘要 目的 检测抗内皮细胞抗体(AECA)在结缔组织病(CTD)相关肺动脉高压(PAH)患者中的阳性率,探讨其可能的致病机制.方法 试验组选取68例CTD相关PAH患者,对照组为12例特发性肺动脉高压患者、61例CTD无PAH的患者、20例慢性阻塞性肺疾病合并肺源性心脏病患者及20名健康人.提取EA.hy926内皮细胞株的膜蛋白质,免疫印迹法检测以上各组患者血清中AECA阳性率,采用X2检验确定特异性的条带.进而应用液相色谱-电喷雾离子阱质谱分析,分离和鉴定AECA特定的靶抗原.结果免疫印迹法检测结果显示,AECA-78 000条带的阳性率在CTD相关PAH患者79%(54/68)和CTD合并肾小球病变的患者71%(15/21),明显高于特发性PAH患者8%(1/12)、CTD无内脏受累患者50%(10/20)、CTD单纯合并肺间质纤维化患者15%(3/20)和健康对照组(P〈0.05或P〈0.01).经蛋白质组学方法 分离鉴定,AECA-78 000的靶抗原成分为膜突蛋白.结论 CTD不同靶器官受累的患者AECA78 000条带的阳性率不同,CTD合并PAH患者和CTD合并肾小球病变的患者可能存在有共同的靶抗原(78 000内皮细胞蛋白质),其成分为膜突蛋白. Objective To detect the positive rate of anti-endothelial cell antibody (AECA) in patients with pulmonary arterial hypertension (PAH) associated with connective tissue diseases(CTD)and to investigate the specific target antigen.Methods Sera of 68 patients with CTD associated PAH were collected to detect AECA by Western blotting with extracted membrane protein of the endothelial cell line EA.hy926.Sera of 61 CTD patients without PAH,20 with idiopathic pulmonary arterial hypertension(IPAH),20 with chronic obstructive pulmonary diseases and pulmonary arterial hypertension (COPD-PAH) and 20 healthy donors were collected as controls.The correlation between PAH and specific bands of AECA was studied by X2 test.Liquid chromatography-electrospray ionization mass spectrography was used to detect the target antigens related to PAH associated with CTD.Results The specific molecular size of antigen was 78 000.The AECA-78 000positive rate of CTD patients with PAH was 79% (54/68).not significantly ditierent from that of CTD with glomerulonephritis(71%,15/21),but significantly higher than those of CTD with interstitial lung disease (ILD)(15%,3/20)and CTD without systemic involvement(P〈0.01 and P〈0.05 respectively).also higher than those of IPAH(8%,1/12).The AECA-78 000 was negative in COPD-PAH and healthy controls.The target antigen of AECA-78 000 was identified by proteomic techniques as moesin.Conclusion CTD patients with different target organ involvement have different AECA-78 000 positive rates,which could be frequently detected in CTD associated PAH and those with glomerulonephritis.The common antigen is moesin.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2010年第5期297-300,共4页 Chinese Journal of Rheumatology
基金 基金项目:国家“十一五”科技支撑计划(2006BA101A07、2008BA159802) 中华医学会临床医学科研专项资金(08010270105)
关键词 结缔组织病 肺动脉高压 抗内皮细胞抗体 Connective tissue disease Pulmonary arterial hyper-tension Anti-endothelial cell
  • 相关文献

参考文献14

  • 1Mukerjee D,St George D,Coleiro B,et al.Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension:application of a registry approach.Ann Rheum Dis,2003,62:1088-1093.
  • 2Bodolay E,Csipo I.Gal I.et al.Anti-endothelial cell antibodies in mixed connective tissue disease:frequency and association with clinical symptoms.Clin Exp Rheumatol,2004,22:409-415.
  • 3Taku Y,Masuyama J,Sumiya M,et al.Anti-endothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.J Rheumatol,2004,22:409-415.
  • 4Rich S,Dantzker DR,Ayres SM,et al.Primary pulmonary hypertension:a national prospective study.Ann Intern Med,1987,107:216-223.
  • 5季颖群,张卓莉,陆慰萱.结缔组织病相关肺动脉高压的临床分析[J].中华内科杂志,2006,45(6):467-471. 被引量:35
  • 6Kawut SM,Taichman DB,Archer-Chicko CL,et al.Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis.Chest,2003,123:344-350.
  • 7Renaudineau Y,Dugué C,Dueymes M,et al.Antiendothelial cell antibodies in systemic lupus erythematosns.Autoimmun Rev,2002,1:365-372.
  • 8Negi VS,Tripathy NK,Misra R,et al.Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension.J Rheumatol,1998,25:462-466.
  • 9Cruz D,Keser G,Khamashta MA,et al.Antiendothelial cell antibodies in inflammatory myopathies:distribution among clinical and serologic groups and association with interstitial lung disease.J Rheumatol,2000,27:161-164.
  • 10Tamby MC,Chanseaud Y,Humbert M,et al.Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.Thorax,2005,60:765-772.

二级参考文献10

  • 1Nakagawa N,Osanai S,Ide H,et al.Severe pulmonary hypertension associated with primary Sjogren's syndrome.Intern Med,2003,42:1248-1252.
  • 2Koopmam WJ,Moreland LW,eds.Arthritis and allied conditions.15th ed.Philadelphia:Lippincott Williams & Wilkins,2004.1249-1680.
  • 3Rich S.Primary pulmonary hypertension.The World SymposiumPrimary pulmonary hypertension 1998.
  • 4Fishman AP.Primary pulmonary arterial hypertension:a look back.J Am Coll Cardiol,2004,43(12 Suppl S):2S-4S.
  • 5Alarcon-Segovia D,Deleze M,Oria CV,et al.Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus.A prospective analysis of 500 consecutive patients.Medicine (Baltimore),1989,68:353-365.
  • 6Mukerjee D,Yap LB,Ong V,et al.The myth of pulmonary Raynaud's phenomenon:the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension.Ann Rheum Dis,2004,63:1627-1631.
  • 7MeGoon M,G utterman D,Steen V,et al.Screening,early detection,and diagnosis of pulmonary arterial hypertension:ACCP evidence-based clinical practice guidelines.Chest,2004,126 (1 Suppl):14S-34S.
  • 8Kono H,Inokuma S.Visualization and functional consequence of pulmonary vascular impairment in patients with rheumatic diseases.Chest,2003,124:255-261.
  • 9Badesch DB,Abman SH,Ahearn GS,et al.Medical therapy for pulmonary arterial hypertension:ACCP evidence-based clinical practice guidelines.Chest,2004,126(1 Suppl):35S-62S.
  • 10Gonzalez-Lopez L,Cardona-Munoz EG,Celis A,et al.Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus.Lupus,2004,13:105-112.

共引文献34

同被引文献46

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部